Legal Representation
Attorney
Shannon T. Vale
USPTO Deadlines
Next Deadline
1892 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-17)
Due Date
September 17, 2030
Grace Period Ends
March 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description |
|---|---|---|---|
| Sep 17, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Sep 17, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Aug 11, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Aug 11, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Jul 19, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jul 19, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Jun 5, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Jun 5, 2024 | IUAF | S | USE AMENDMENT FILED |
| Dec 1, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 30, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Nov 30, 2023 | EXT5 | S | SOU EXTENSION 5 FILED |
| Nov 30, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 8, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 6, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Jun 6, 2023 | EXT4 | S | SOU EXTENSION 4 FILED |
| Jun 6, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 15, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 11, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Nov 11, 2022 | EXT3 | S | SOU EXTENSION 3 FILED |
| Nov 11, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 11, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 9, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED |
| May 9, 2022 | EXT2 | S | SOU EXTENSION 2 FILED |
| May 9, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 7, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Dec 7, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Dec 7, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Dec 7, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Dec 3, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Dec 3, 2021 | EXT1 | S | SOU EXTENSION 1 FILED |
| Dec 3, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 8, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 13, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 13, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 24, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 11, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 25, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 15, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 12, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetic foot ulcers; Pharmaceutical preparations for accelerating healing of human tissue; Therapeutic gels intended for topical use on skin and mucous membranes, intended to accelerate the healing of skin surface wounds and diabetic foot ulcers; Pharmaceuticals for the treatment of acute radiation syndrome; Pharmaceuticals for the treatment of COVID-19; Pharmaceutical products for the prevention and treatment of Degenerative Brain Diseases and Traumatic Brain Injury (TBI)
First Use Anywhere:
20120800
First Use in Commerce:
20120800
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...